extract: 2025-07-24-kff-medicare-advantage-2025-enrollment-update
Pentagon-Agent: Ganymede <F99EBFA6-547B-4096-BEEA-1D59C3E4028A>
This commit is contained in:
Teleo Agents
parent
54869f7e31
commit
7dc9123f4a
5 changed files with 83 additions and 1 deletions
|
|
@ -23,6 +23,12 @@ Devoted was built from scratch on the Orinoco platform — a unified AI-native o
|
|||
|
||||
Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9 billion annual technology spend directed at optimizing existing infrastructure (consolidating 18 EMRs, AI scribing within legacy workflows) rather than rebuilding around prevention is textbook proxy inertia. The margin from coding arbitrage rationally prevents pursuit of the purpose-built alternative.
|
||||
|
||||
|
||||
### Additional Evidence (extend)
|
||||
*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-15*
|
||||
|
||||
UHG gained 505K members while Humana lost 297K in 2025, showing market consolidation favoring the largest incumbent even as purpose-built plans like Devoted grow faster percentage-wise. The oligopoly structure (UHG + Humana = 46%) suggests that while tech-first plans can achieve high growth rates, absolute market power remains concentrated in acquisition-based vertical integrators.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -29,6 +29,12 @@ Politicians face a choice between:
|
|||
|
||||
The political economy strongly favors Option A. The fiscal pressure builds continuously through the 2030s as the exhaustion date approaches, creating windows for reform regardless of partisan control.
|
||||
|
||||
|
||||
### Additional Evidence (confirm)
|
||||
*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-15*
|
||||
|
||||
2025 MA spending gap reached $84B (20% per-person premium over FFS) with CBO projecting 64% penetration by 2034. At current overpayment rates, 64% penetration implies ~$150B+ annual spending gap, creating arithmetic pressure for reform independent of political preferences.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -291,6 +291,12 @@ PACE provides the most comprehensive real-world test of the prevention-first att
|
|||
|
||||
The Commonwealth Fund's 2024 international comparison provides evidence that the prevention-first attractor state is not theoretical — peer nations demonstrate it empirically. The top performers (Australia, Netherlands) achieve better health outcomes with lower spending as percentage of GDP, suggesting their systems have structural features that prevent rather than treat. The US paradox (2nd in care process, last in outcomes, highest spending, lowest efficiency) reveals a system optimized for treating sickness rather than producing health. The efficiency domain rankings (US among worst — highest spending, lowest return) quantify the cost of a sick-care attractor state. The international benchmark shows that systems with better access, equity, and prevention orientation achieve superior outcomes at lower cost, suggesting the prevention-first attractor state is achievable and economically superior to the current US sick-care model.
|
||||
|
||||
|
||||
### Additional Evidence (challenge)
|
||||
*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-15*
|
||||
|
||||
MA spending gap grew 4.7x while enrollment doubled (2015-2025), with federal government paying 20% premium over FFS despite aligned payment structure. If value-based care creates prevention flywheel, per-capita costs should decline with scale. Instead, overpayment is structural and compounding, suggesting current MA implementation captures arbitrage opportunities rather than building prevention infrastructure.
|
||||
|
||||
---
|
||||
|
||||
Relevant Notes:
|
||||
|
|
|
|||
|
|
@ -0,0 +1,48 @@
|
|||
{
|
||||
"rejected_claims": [
|
||||
{
|
||||
"filename": "medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "medicare-advantage-market-is-an-oligopoly-with-unitedhealthgroup-and-humana-controlling-46-percent-despite-nominal-plan-choice.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "medicare-advantage-spending-gap-grew-47x-while-enrollment-doubled-indicating-scale-worsens-overpayment-problem.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
{
|
||||
"filename": "chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-disease-management-infrastructure.md",
|
||||
"issues": [
|
||||
"missing_attribution_extractor"
|
||||
]
|
||||
}
|
||||
],
|
||||
"validation_stats": {
|
||||
"total": 4,
|
||||
"kept": 0,
|
||||
"fixed": 4,
|
||||
"rejected": 4,
|
||||
"fixes_applied": [
|
||||
"medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program.md:set_created:2026-03-15",
|
||||
"medicare-advantage-market-is-an-oligopoly-with-unitedhealthgroup-and-humana-controlling-46-percent-despite-nominal-plan-choice.md:set_created:2026-03-15",
|
||||
"medicare-advantage-spending-gap-grew-47x-while-enrollment-doubled-indicating-scale-worsens-overpayment-problem.md:set_created:2026-03-15",
|
||||
"chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-disease-management-infrastructure.md:set_created:2026-03-15"
|
||||
],
|
||||
"rejections": [
|
||||
"medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-supplement-to-dominant-program.md:missing_attribution_extractor",
|
||||
"medicare-advantage-market-is-an-oligopoly-with-unitedhealthgroup-and-humana-controlling-46-percent-despite-nominal-plan-choice.md:missing_attribution_extractor",
|
||||
"medicare-advantage-spending-gap-grew-47x-while-enrollment-doubled-indicating-scale-worsens-overpayment-problem.md:missing_attribution_extractor",
|
||||
"chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-disease-management-infrastructure.md:missing_attribution_extractor"
|
||||
]
|
||||
},
|
||||
"model": "anthropic/claude-sonnet-4.5",
|
||||
"date": "2026-03-15"
|
||||
}
|
||||
|
|
@ -7,9 +7,13 @@ date: 2025-07-24
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: data
|
||||
status: unprocessed
|
||||
status: enrichment
|
||||
priority: high
|
||||
tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
|
||||
processed_by: vida
|
||||
processed_date: 2026-03-15
|
||||
enrichments_applied: ["Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md", "the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md", "medicare-fiscal-pressure-forces-ma-reform-by-2030s-through-arithmetic-not-ideology.md"]
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -79,3 +83,15 @@ tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
|
|||
PRIMARY CONNECTION: [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
|
||||
WHY ARCHIVED: Essential market structure data — the enrollment trajectory and concentration metrics ground claims about where the US healthcare system is actually heading vs. where theory says it should go.
|
||||
EXTRACTION HINT: The spending gap growing 4.7x while enrollment only doubled is the key structural insight — scale is making the overpayment problem worse, not better.
|
||||
|
||||
|
||||
## Key Facts
|
||||
- MA enrollment grew 4% from 2024 to 2025, adding 1.3M beneficiaries
|
||||
- Special Needs Plans represent 21% of MA enrollment in 2025, up from 14% in 2020
|
||||
- D-SNPs (dual-eligible) represent 83% of all SNP enrollment at 6.1M beneficiaries
|
||||
- CVS Health (Aetna) holds 12% MA market share with 4.1M enrollees
|
||||
- Elevance Health holds 7% MA market share with 2.2M enrollees
|
||||
- Kaiser Foundation holds 6% MA market share with 2.0M enrollees
|
||||
- Individual MA plans represent 62% of enrollment (21.2M)
|
||||
- Employer/union group MA plans represent 17% of enrollment (5.7M) with first year of flat growth in ~10 years
|
||||
- I-SNPs (institutional) represent 2% of SNP enrollment at 115K beneficiaries
|
||||
|
|
|
|||
Loading…
Reference in a new issue